Mallinckrodt plc (NYSE: MNK) and Cadence Pharmaceuticals, Inc. (Nasdaq: CADX) announced that they have entered into a definitive agreement under ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE